Barely Significant
← all excerpts

Phase I clinical evaluation of <sup>99m</sup>Tc-labeled Affibody molecule for imaging HER2 expression in breast cancer.

Theranostics · 2023 · PMC10526658 · PMID 37771776

Europe PMCDOI
1
hedged sentence
0.0050
closest p · 0.1× alpha
0.0050
boldest claim

The sentences

highly significantP < 0.005actually significant
In contrast, injection of 1000 μg resulted in a highly significant difference (P < 0.005, Mann-Whitney U test) between uptake in tumors with high and low HER2 expression.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.